Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

Regenstrief Institute data experts are actively working to further the understanding of COVID-19 through real-world data. In the last week, the Regenstrief chief executive officer and a vice president have been lead authors on papers published in the U.S. Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report (MMWR).

Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., is first author on a study analyzing the vaccine effectiveness for  people who are immunocompromised, which is published in the MMWR. Vice President for Data and Analytics Shaun Grannis, M.D., M.S., is the first author on a paper about the effectiveness of COVID-19 vaccines  against the Delta variant, also published in the MMWR. He made significant contributions to a paper on vaccine effectiveness in the New England Journal of Medicine and another paper in the MMWR comparing immunity provided by vaccinations to immunity provided by prior infection.

The papers, in order of publication, and list of Regenstrief authors, are:

    • Third author: Dr. Grannis
    • Other Regenstrief authors: Brian Dixon, PhD, MPA, William Fadel, PhD, and Minish Ramesh Valvi, DrPH, MBBS, MPH 
    • First author: Dr. Grannis. 
    • Second author: Dr. Grannis 
    • Other Regenstrief authors: Dr. Dixon, Dr. Embí, Dr. Fadel and Dr. Valvi 

These studies are all work of the CDC’s VISION Network, which is made up of seven organizations across the country — including Regenstrief — that submit real-world data for analysis.

About Peter Embí, M.D., M.S 

In addition to serving as the president and CEO of Regenstrief Institute, Peter Embí, M.D., M.S. is the Leonard Betley Professor of Medicine and associate dean for informatics and health services research at Indiana University School of Medicine, associate director of informatics with Indiana Clinical and Translational Sciences Institute and vice president for Learning Health Systems with Indiana University Health. 

About Shaun Grannis, M.D., M.S.  

In addition to his role as the vice president of data and analytics at Regenstrief Institute, Shaun Grannis, M.D., M.S., is the Regenstrief Chair in Medical Informatics and a professor of family medicine at Indiana University School of Medicine. 

Related Influence

Nov 01, 2021 • Influence
Regenstrief scientist highlights benefits of gene-specific approaches to colon cancer surveillance
Regenstrief Research Scientist Jennifer K. Maratt, M.D., M.S., co-authored a commentary in Gastroenterology about the benefits of gene-specific surveillance colonoscopy strategies for Lynch Syndrome, an inherited syndrome that increases the risk for colon cancer. The editorial was published in conjunction with a paper from Columbia University. In that study, researchers created different surveillance strategies for…
Continue Reading >
Oct 27, 2021 • Influence
Regenstrief research scientist co-authors national editorial to improve dementia care
Christopher M. Callahan, M.D., a Regenstrief Institute research scientist, co-authored an editorial in the Journal of the American Geriatrics Society (JAGS), “Improving care for dementia: Re-imagining the advocacy playbook,” that observes dementia care focused at the community, policy, and societal levels urgently requires more attention from researchers and clinicians. According to the Geriatrics Healthcare Professionals…
Continue Reading >